Arjun Goyal
Managing Director at Vida Ventures, LLC
Arjun Goyal
Managing Director at Vida Ventures, LLC
Boston, Massachusetts
Overview
Work Experience
Co-Founder and Managing Director
2017 - Current
Vida Ventures is a life sciences investment firm founded in 2017 and manages ~$2B AUM. We are passionate about building and funding breakthroughs in biomedicine. Our mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful impact for patients.
Venture Capital Advisor
2022
Venture Capital Advisors (VCAs) are general partners from VC firms providing HBS/ Harvard students & faculty with fundraising information, and feedback on their idea, business models, and other core aspects of their new ventures.
Member Board Of Directors
2021
Alterome Therapeutics is developing alteration-specific therapeutics for high value oncology targets
Co-Founder and Board Member
2021
Affini-T Therapeutics is developing cell therapies focused on oncogenic drivers for solid tumors
Member Board Of Directors
2021
Centessa Pharmaceuticals is developing medicines focused on rare diseases and immuno-oncology NASDAQ: CNTA Compensation Committee Nom/Gov Committee Audit Committee
Member Board Of Directors
2020
Quanta Therapeutics is developing small molecules to oncogenic drivers Compensation Committee Nom/ Gov Committee
Member Board Of Directors
2020
Scorpion Therapeutics is developing medicines for oncology Compensation Committee, Chair Nom/ Gov Committee
Member Board Of Directors
2017
Pionyr Immunotherapeutics is developing medicines focused on modulating the tumor microenvironment Gilead acquired Pionyr for ~$1.5B total consideration
Member Board Of Directors
2019 - 2020
Kinnate Biopharma is developing therapies for BRAF and FGFR driven cancers NASDAQ: KNTE
Investor
2018 - 2020
Asklepios Bio develops gene therapies for rare diseases Bayer acquired Ask Bio for a total consideration of ~$4B